"And that's a good question for me when we file the product. And at that point in time, we'll be more prepared to talk specifically about some of our thoughts and plans associated with the overall marketing program for the drug."
Next quarterly call, we have to get you on the list to ask some questions of Art that the analysts don't ask. I'm actually wondering how hard that would be to get on the official list for a Q&A session. You've probably written more about ANIP and have had more readers than any who do get invited. Consider.
Market Data 
Markets 
AI
